Bloomberg News

Teva Falls Most Since October, Narrows Gap With U.S. Stock

May 20, 2012

Teva Pharmaceutical Industries Ltd. (TEVA) fell the most since October in Tel Aviv, narrowing the gap with its U.S.-traded shares.

The stock of the world’s largest generic drugmaker dropped 3.6 percent, the biggest decline since Oct. 4, to 150.40 shekels, or the equivalent of $39.33, at the close in Tel Aviv. Teva’s stock in New York fell 7 percent last week to close at $38.90 on May 18.

To contact the reporter on this story: David Wainer in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Toyota's Hydrogen Man
blog comments powered by Disqus